To provide for certain temporary waivers with respect to the 340B drug discount program due to the COVID-19 public health emergency, and for other purposes.
About This Bill
Committee
Latest Action · July 29, 2020
Referred to the House Committee on Energy and Commerce.
This bill waives certain eligibility requirements for hospitals participating in the 340B drug discount program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers) during the COVID-19 (i.e., coronavirus disease 2019) public health emergency. For example, the bill waives the required minimum proportion of low-income patients served for hospitals that were participating or applied to participate in the program prior to the COVID-19 emergency.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.